TGFB1 and Down syndrome: In TGF-β-driven syndromes, such as Marfan and Loeys–Dietz, angiotensin receptor blockers (e.g., losartan) have shown efficacy in attenuating aortic root growth, with ongoing trials evaluating optimal dosing and long-term outcomes [109].